Merieux Equity Partners (investor - Private Equity)

See something wrong or missing? Let us know
Offices:Lyon

Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector

Average round investment:33.18M USD
Average number per year:1.7
Distribution: 2025 (1)2024 (2)2023 (2)2022 (4)2021 (1) See the entire list
Mostly invests in: France France (6) Health services (12)
See the entire list

Showing 3 of 12 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Merieux Equity Partners

Name Criteria
United States Compound VC
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Software Services, Manufacturing, Competitive Intelligence, Pharma, Hardware, AI (big data)
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: France, United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Sweden Axel Christofer Hedfors
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Software Services, Manufacturing, Hardware
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom, Sweden
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Sweden Consensus Småbolag
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, Mobile
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Sweden
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Global Emerging Markets
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, Manufacturing, Pharma
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: France, Belgium
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
France La Maison Partners
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, Pharma, AI (big data)
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: France, United Kingdom, Sweden
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Turkey Revo Capital
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, Competitive Intelligence, Mobile
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United Kingdom Scottish Equity Partners (SEP)
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Software Services, Manufacturing, Competitive Intelligence, AI (big data), Mobile
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: France, United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom NatWest Group
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Software Services, Competitive Intelligence, AI (big data)
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United States Energize Ventures
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Software Services, Manufacturing, Competitive Intelligence, Hardware, AI (big data), Mobile
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: France, Switzerland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Quantum Light
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, Competitive Intelligence, AI (big data), Mobile
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Top